Eli Lilly is releasing a cheaper version of its weight loss drug Zepbound.hit a new intraday record and closed at a record high on Monday. The 30-stock index closed up 65.44 points, or 0.16%, after rallying more than 200 points earlier in the day. Thedidn't fare as well, falling 0.32% and 0.85%, respectively. Traders appeared to be favoring other sectors in the market and rotating out of tech. And AI darlingclosed down 2.3% ahead of its earnings report due Wednesday afternoon.
The new form of the drug is roughly half of its usual monthly list price: Eli Lilly is now selling 2.5-milligram and 5-milligram single-dose vials of Zepbound for $399 per month and $549 per month, respectively, via its direct-to-consumer website. That compares with current list prices of roughly $1,000 per month before insurance and other rebates for Zepbound and other weight loss drugs, such as Novo Nordisk's Wegovy.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Sumber: CNBC - 🏆 12. / 72 Baca lebih lajut »
Sumber: NBCLA - 🏆 319. / 59 Baca lebih lajut »
Sumber: CNBC - 🏆 12. / 72 Baca lebih lajut »
Sumber: NBCNewYork - 🏆 270. / 63 Baca lebih lajut »
Sumber: nbcchicago - 🏆 545. / 51 Baca lebih lajut »
Sumber: CNBC - 🏆 12. / 72 Baca lebih lajut »